Endo to Report Second Quarter 2025 Financial Results on August 6, 2025
Rhea-AI Summary
Endo (OTCQX: NDOI) has scheduled its second quarter 2025 financial results announcement for August 6, 2025, before the market opens. The company will host a conference call at 8:00 a.m. ET on the same day.
Investors can access the audio webcast through the company's Investor Relations website at investor.endo.com. For those preferring a conference line, dial-in numbers are provided: 800-836-8184 (U.S. and Canada toll-free) or 646-357-8785 (international). Participants should join 10 minutes before the start time. A webcast replay will be available after the event.
Positive
- None.
Negative
- None.
News Market Reaction – NDOI
In the trading session that priced this news, NDOI gained 3.09%, reflecting a moderate positive market reaction.
Data tracked by StockTitan Argus on the day of publication.
AI-generated analysis. How Rhea-AI works. Not financial advice.
The audio webcast may be accessed through the Investor Relations section of the Company's website at investor.endo.com under Events & Presentations. To access the call through a conference line, participants may dial 800-836-8184 (
About Endo
Endo is a diversified pharmaceutical company boldly transforming insights into life-enhancing therapies. Our passionate team members collaborate to develop and deliver these essential medicines. Together, we are committed to helping everyone we serve live their best life. Learn more at www.endo.com or connect with us on LinkedIn.
View original content to download multimedia:https://www.prnewswire.com/news-releases/endo-to-report-second-quarter-2025-financial-results-on-august-6-2025-302509530.html
SOURCE Endo, Inc.